{
    "clinical_study": {
        "@rank": "124432", 
        "arm_group": [
            {
                "arm_group_label": "1064nm Q-switch Laser", 
                "arm_group_type": "Active Comparator", 
                "description": "The 1064 Q-Switch Laser is a medical device that uses a focused laser to remove dark pigment (color) from the skin."
            }, 
            {
                "arm_group_label": "Glycolic Acid Peels", 
                "arm_group_type": "Active Comparator", 
                "description": "A Glycolic Acid Chemical Peel is a mild skin treatment used to correct uneven texture and color by removing dead cells from the skin's outermost layer."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to find out the safety and effectiveness of 1064 Q-Switch Laser\n      Therapy compared to Glycolic Acid Chemical Peels for the treatment of melasma."
        }, 
        "brief_title": "A Pilot Study Testing 1064nm Q-switch Laser Versus Glycolic Acid Peels for the Treatment of Melasma", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Melanosis", 
        "condition_browse": {
            "mesh_term": "Melanosis"
        }, 
        "detailed_description": {
            "textblock": "Participants in this study will be patients at the dermatology clinic who are clinically\n      diagnosed with at least a 2X2 cm patch of melasma on each side of their face (forehead or\n      cheek). Starting at 2 weeks before treatment (week 2), both sides will be pretreated and\n      primed with 4% hydroquinone with, if necessary, 2.5% hydrocortisone cream BID. On the\n      treatment day (2-weeks) and 6-weeks one half of the subject's face will receive glycolic\n      acid peels and the other half of the face will receive  1064nm  Q-switch laser. This study\n      is a pilot study designed to determine feasibility of these procedures."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subjects aged 18 years or older\n\n          2. Subjects with at least a 2 x 2 cm patch of melasma on each side of the face (forehead\n             or cheek)\n\n          3. Subjects  in general good health\n\n          4. Subjects must be willing and able to understand and provide informed consent for the\n             use of their tissue and communicate with the investigator\n\n          5. Subjects must be willing to not apply other treatment options for melasma during the\n             course of the study\n\n        Exclusion Criteria:\n\n          1. Subjects under 18 years of age\n\n          2. Subjects who are pregnant and/or lactating\n\n          3. Subjects who are unable to understand the protocol or to give informed consent\n\n          4. Subjects diagnosed with mental illness\n\n          5. Subjects who have concurrent active uncontrolled disease to facial area (i.e\n             uncontrolled acne)\n\n          6. Subjects who have had a chemical peel in the past 3 months\n\n          7. Subjects who have used a prescribed retinoid in the past 3 months\n\n          8. Subjects with a bleeding disorder\n\n          9. Subjects with a history of abnormal wound healing\n\n         10. Subjects with a history of abnormal scarring\n\n         11. Subjects who report being allergic to glycolic acid"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976273", 
            "org_study_id": "STU84150"
        }, 
        "intervention": [
            {
                "arm_group_label": "1064nm Q-switch Laser", 
                "intervention_name": "1064nm Q-switch Laser", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Glycolic Acid Peels", 
                "intervention_name": "Glycolic Acid Peels", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Glycolic acid"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 22, 2014", 
        "location": {
            "contact": {
                "email": "research.nuderm@norhtwestern.edu", 
                "last_name": "Emily Poon, PhD", 
                "phone": "312-695-4761"
            }, 
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611"
                }, 
                "name": "Northwestern University Department of Dermatology"
            }, 
            "investigator": {
                "last_name": "Murad Alam, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Pilot Study Comparing the Efficacy of 1064 Q-switch Laser vs. Glycolic Acid Peels for the Treatment of Melasma: A Randomized Control Trial", 
        "overall_contact": {
            "email": "research.nuderm@northwestern.edu", 
            "last_name": "Emily Poon, PhD", 
            "phone": "312-695-4761"
        }, 
        "overall_official": {
            "affiliation": "Northwestern University", 
            "last_name": "Murad Alam, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome was a blinded rating of the treatment area (1064nm Q-switch Laser Versus Glycolic Acid Peels) with the best overall cosmetic appearance. A dermatologist will blindly evaluate the treated areas of each side from live subjects at baseline and on the final follow up visit (week 10).", 
            "measure": "Change in best overall cosmetic appearance (right side or left side better)rated by a blinded dermatologist from baseline to week 10", 
            "safety_issue": "No", 
            "time_frame": "1 hour at baseline and week 10"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976273"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Northwestern University", 
            "investigator_full_name": "Murad Alam", 
            "investigator_title": "Professor in Dermatology, Otolaryngology - Head and Neck Surgery, and Surgery-Organ Transplantation", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Northwestern University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Northwestern University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}